| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention relates to industrial microbiology, namely to application of strain of Lactobacillus casei, deposited under number I-1518, for obtaining composition for stimulating response of cells-natural killers in adult individual with common respiratory infectious disease, where composition also contains bacteria Lactobacillus bulgaricus and Streptococcus thermophilus.EFFECT: application of composition, containing Lactobacillus casei I-1518, makes it possible to increase resistance of organism to common respiratory infections, in particular to rhinopharyngitis or laryngitis.17 cl, 12 tbl, 1 dwg, 3 ex |
